Part 2/8:
The affected wine was sold between April 15th and August 26th. In response, the retailer sent out notices to all members who bought the product, highlighting the potential hazard and urging prompt disposal to prevent injuries from shattered glass or flying debris.
FDA Targets Misleading Telehealth Promotions
The Food and Drug Administration (FDA) is cracking down on certain telehealth companies that promote unregulated or misleading medication options. Chief among these are firms like Hims and Hers, which have built a multibillion-dollar enterprise by marketing lower-cost alternatives to high-profile obesity injections, such as Wegovy and Ozempic.